Meta Pixel

News and Announcements

Universal Biosensors (ASX:UBI) CEO Interview

  • Published July 08, 2015 4:08PM UTC
  • Publisher Wholesale Investor
  • Categories Executive Interviews

Universal Biosensors (ASX:UBI) is a specialist medical diagnostics company developing and manufacturing test systems for point-of-care (POC) medical professionals and home use.

UBI’s core technology is a disposable, multi-layer test strip, which uses its proprietary electrochemical sensor to rapidly and accurately measure biomarkers in the blood.

The first product developed by UBI with LifeScan (a Johnson & Johnson company) is a blood glucose measurement device and is on the market and generating revenues for UBI. The second product developed by UBI in collaboration with Siemens Healthcare has also been launched.

The global point-of-care diagnostics market is estimated to be worth nearly US$17 billion a year and growing.

Please listen to Mr Paul Wright, the CEO of Universal Biosensors.

Company Updates
The A$20.4 Million Inertia Trap: How Kepa Software Is Unlocking Value in Enterprise Capital Allocation

A government agency renewed the same maintenance decision nine years running, because auditing the original choice was deemed too expensive. When the portfolio was finally tested, A$20.4 million of low value spend was identified in a single year. Kepa Software’s capital governance platform was built to expose and eliminate precisely these boardroom blind spots. For […]

Company Updates
The prefab company that deliberately leaves part of the house unbuilt

BuiltQuik prefabricates the floor and roof structure and stops there. Co-founder Ryan Mullaney argues the omission is the product. Prefabricated housing usually means a factory. A large central facility, identical modules, limited room to move on design, and a logistics problem getting the finished box to site. BuiltQuik builds the opposite, and the design decision […]

Join over 45,000+ sophisticated investors

Join Now